Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06621277
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-23
Brief Title:
JUMP_START - Optimization of Care for Young Cancer Patients with Gastrointestinal Tumors
Sponsor:
None
Organization:
None
Study Overview
Official Title:
JUMP_START - Optimization of Care for Young Cancer Patients with Gastrointestinal Tumors
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
JUMP_START
Brief Summary:
JUMP_START aims to assess the needs of individuals aged 50 years with gastrointestinal GI tumors and implement a tailored support and counseling program at the University Hospital Heidelberg and the National Center for Tumor Diseases NCT
In phase 1A 12-15 individuals aged 50 years with GI tumors will be interviewed via telephone using semi-structured interviews to obstain a detailed understanding of the life situation the burdens and the care situation within the structures of the NCT Heidelberg
In phase 1B the care networks of young patients with GI tumors beyond the NCT including the analysis of changes and important access routespossible gatekeepers will be explored using so-called ego-centered network analyses in comparison with patients who received a GI tumor diagnosis after the age of 50
In response to the results of phase 1A and 1B the care services for young patients with GI tumors will be optimized and tailored counseling programs will be developed in phase 2
These project phases will be accompanied by Quality of Life assessments using European Organisation for Research and Treatment of Cancer EORTC questionnaires All patients with GI tumors regardless of potential inclusion in phase 1A or 1B will receive the EORTC questionnaires once In phase 2 Quality of Life will be assessed every 6 months
In phase 1A 12-15 individuals aged 50 years with GI tumors will be interviewed via telephone using semi-structured interviews to obstain a detailed understanding of the life situation the burdens and the care situation within the structures of the NCT Heidelberg
In phase 1B the care networks of young patients with GI tumors beyond the NCT including the analysis of changes and important access routespossible gatekeepers will be explored using so-called ego-centered network analyses in comparison with patients who received a GI tumor diagnosis after the age of 50
In response to the results of phase 1A and 1B the care services for young patients with GI tumors will be optimized and tailored counseling programs will be developed in phase 2
These project phases will be accompanied by Quality of Life assessments using European Organisation for Research and Treatment of Cancer EORTC questionnaires All patients with GI tumors regardless of potential inclusion in phase 1A or 1B will receive the EORTC questionnaires once In phase 2 Quality of Life will be assessed every 6 months
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None